It was shown that the system blocked the PLK1 gene in addition to its effect on tumor growth and reduced toxicity, which demonstrated the synergistic effect of drug and siRNA combination against castrate-resistance PCa[158]. The gene discussed is PLK1; the disease is posterior cortical atrophy.